Ann: Imugene HER-Vaxx and CHECKVacc to be Featured at ESMO, page-54

Agree rolly, one possibility is that there’s one BP who have their eye firmly on HER-Vaxx, they’re involved with the MM’s/shorters to keep the SP suppressed as much as possible & don’t mind funding/incurring losses to keep the SP suppressed until a deal is completed. As more data is released it will obviously be harder to contain the SP so a deal may not be that far away as this can’t be sustained forever.
If I were to make an offer for a very promising cancer treatment, I’d rather be negotiating with the SP around 10 cents as opposed to 50 - regardless, I’m happy to sit back & watch what unfolds . .